The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

This was the stock's second consecutive day of losses.

The Feb. 21 cyberattack on Change Healthcare crippled financial operations for hospitals, insurers, pharmacies and medical groups nationwide. In July, the organization began sending out breach ...

PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices.

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...

The ASC industry is facing two new, opposing forces: consolidation by large ASC chains and independent ASCs with non-traditional business models.

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.